J. Barrio

发表

MR quantification of hepatic iron concentration.

J. Emparanza, J. Alústiza, J. Artetxe, 2004, Radiology.

Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3).

J. Gisbert, A. Montserrat, I. Ordás, 2014, Journal of Crohn's & colitis.

Safety of Thiopurine Therapy in Inflammatory Bowel Disease: Long-term Follow-up Study of 3931 Patients

J. Mate, J. Gisbert, I. Ordás, 2013, Inflammatory bowel diseases.

Letter: the role of stent in the treatment of Crohn's disease strictures – authors’ reply

J. Barrio, F. González‐Huix, F. Fernández-Bañares, 2013, Alimentary pharmacology & therapeutics.

Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent.

J. Gisbert, X. Calvet, M. Chaparro, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy

J. Gisbert, X. Calvet, I. Ordás, 2010, Gut.

UEG Week 2015 Oral Presentations

J. Gisbert, X. Jouven, H. Sokol, 2015, United European Gastroenterology Journal.

Self-expandable metal stents versus endoscopic balloon dilation for the treatment of strictures in Crohn's disease (ProtDilat study): an open-label, multicentre, randomised trial.

D. Busquets, J. Barrio, V. Sánchiz, 2022, The lancet. Gastroenterology & hepatology.

Screening for latent tuberculosis infection in patients with inflammatory bowel disease: Can interferon-gamma release assays replace the tuberculin skin test?

J. Barrio, J. Cabriada, R. Ruiz-Zorrilla, 2019, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease

J. Gisbert, M. Chaparro, S. Riestra, 2018, Journal of Crohn's & colitis.

Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: A multicenter retrospective cohort study.

J. Gisbert, X. Calvet, M. Piqueras, 2019, Journal of Crohn's & colitis.

[The prevalence of hepatitis C virus infection].

J. Emparanza, M. García-Bengoechea, J. Barrio, 1998, Gastroenterologia y hepatologia.

Fourteen‐day high‐dose esomeprazole, amoxicillin and metronidazole as third‐line treatment for Helicobacter pylori infection

J. Gisbert, X. Calvet, J. Barrio, 2017, International journal of clinical practice.

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study

J. Gisbert, F. Rodríguez‐Artalejo, X. Calvet, 2021, Journal of clinical medicine.

Clinical status, quality of life, and work productivity in Crohn's disease patients after one year of treatment with adalimumab.

J. Barrio, F. Muñoz, P. Lázaro, 2017, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trial.

J. Gisbert, X. Calvet, J. Barrio, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[Porphyria cutanea tarda. An analysis of HFE gene mutations, hepatitis viruses, alcohol intake, and other risk factors in 54 patients from Guipúzcoa, Basque Country, Spain].

E. Utrilla, A. Castiella, P. Otazua, 2008, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU

X. Calvet, M. Piqueras, Miguel A Montoro-Huguet, 2022, Journal of clinical medicine.

Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease

J. Gisbert, M. Chaparro, S. Riestra, 2017, Journal of Crohn's & colitis.

Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients

J. Gisbert, X. Calvet, D. Bernardo, 2018, Digestive Diseases and Sciences.

EoE CONNECT, the European Registry of Clinical, Environmental, and Genetic Determinants in Eosinophilic Esophagitis: rationale, design, and study protocol of a large-scale epidemiological study in Europe

E. Savarino, S. Carrión, S. Fernández-Fernández, 2022, Therapeutic advances in gastroenterology.

Long-Term Loss of Response in Proton Pump Inhibitor-Responsive Esophageal Eosinophilia Is Uncommon and Influenced by CYP2C19 Genotype and Rhinoconjunctivitis

A. Bredenoord, E. Dellon, J. Zamorano, 2015, The American Journal of Gastroenterology.

Long‐term durability of response to adalimumab in Crohn's disease

J. Gisbert, J. Panés, M. Andreu, 2012, Inflammatory bowel diseases.

Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry

J. Gisbert, F. Rodríguez‐Artalejo, X. Calvet, 2017, The American Journal of Gastroenterology.

Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients.

C. Sánchez-Montes, S. Riestra, J. Barrio, 2012, World journal of gastroenterology.

Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study)

R. Sanchez-Ocana, J. Barrio, L. Fernández-Salazar, 2016, Scandinavian journal of gastroenterology.

Resources Utilization and Costs the Year Before and After Starting Treatment with Adalimumab in Crohn's Disease Patients

S. Riestra, J. Barrio, F. Muñoz, 2015, Inflammatory bowel diseases.

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

Fraser Cummings, S. Vermeire, E. Savarino, 2022, The Lancet.

Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study

J. Gisbert, X. Calvet, J. Panés, 2009, The American Journal of Gastroenterology.

Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

J. Gisbert, X. Calvet, M. Piqueras, 2022, Frontiers in Medicine.

Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry

J. Gisbert, X. Calvet, M. Piqueras, 2021, Journal of Crohn's & colitis.

Perioperative management and early complications after intestinal resection with ileocolonic anastomosis in Crohn’s disease: analysis from the PRACTICROHN study

J. Barrio, A. Gutiérrez, M. Martín-Arranz, 2019, Gastroenterology report.

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study

J. Gisbert, X. Calvet, J. Tosca, 2017, The American Journal of Gastroenterology.

Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents

J. Gisbert, X. Calvet, I. Ordás, 2020, Journal of gastroenterology and hepatology.

Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry

J. Gisbert, X. Calvet, M. Piqueras, 2020, Digestive Diseases and Sciences.

Endoscopic treatment with self‐expanding metal stents for Crohn's disease strictures

M. Pérez-Miranda, J. Barrio, F. González‐Huix, 2012, Alimentary pharmacology & therapeutics.

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.

J. Gisbert, X. Calvet, M. Dominguez-Cajal, 2019, Inflammatory bowel diseases.

EFFECTIVENESS AND SAFETY OF THE SEQUENTIAL USE OF A SECOND AND THIRD ANTI-TNF AGENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY SHORT TITLE: Sequential use of anti-TNFs in IBD patients AUTHORS

Mariana, J. Gisbert, X. Calvet, 2020 .

Multicriteria Decision Analysis for Updating of Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units in Spain

X. Calvet, J. Panés, M. Chaparro, 2022, Journal of Crohn's & colitis.

Hemoperitoneum caused by hemorrhage of tubal vessels, a previously undescribed complication of colonoscopy.

M. Pérez-Miranda, J. Barrio, R. Atienza, 2011, Endoscopy.

UCTN – Unusual cases and technical notes E 93

M. Pérez-Miranda, J. Barrio, C. Cuesta, 2011 .

[Spontaneous bacteremia due to Salmonella hadar in liver cirrhosis with transjugular intrahepatic portosystemic shunt].

A. Castiella, J. Barrio, J. Arenas, 1999, Gastroenterologia y hepatologia.

Sigmoid perforation caused by a migrated biliary stent and closed with clips

C. de la Serna-Higuera, M. Pérez-Miranda, J. Barrio, 2012, Endoscopy.

Bismuth quadruple regimen with tetracycline or doxycycline versus three‐in‐one single capsule as third‐line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp‐EuReg)

F. Mégraud, C. O'Morain, J. Gisbert, 2020, Helicobacter.

Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection

J. Gisbert, M. Fernández-Bermejo, L. Rodrigo, 2014, Digestive Diseases and Sciences.

Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin.

J. Gisbert, L. Rodrigo, J. Barrio, 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Helicobacter pylori second‐line rescue therapy with levofloxacin‐ and bismuth‐containing quadruple therapy, after failure of standard triple or non‐bismuth quadruple treatments

J. Gisbert, A. Federico, A. Lucendo, 2015, Alimentary pharmacology & therapeutics.

Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study

C. O'Morain, J. Gisbert, A. Lucendo, 2015, Alimentary pharmacology & therapeutics.

Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments.

J. Gisbert, A. Federico, A. Lucendo, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Helicobacter Pylori First-Line and Rescue Treatments in the Presence of Penicillin Allergy

J. Gisbert, L. Rodrigo, J. Barrio, 2015, Digestive Diseases and Sciences.

[Clinical aspects and endoscopic management of gastrointestinal bleeding from Dieulafoy's lesion].

J. Ulla, J. Barrio, J. Turnés, 2007, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry

E. Savarino, E. Laserna-Mendieta, A. Lucendo, 2020, Alimentary pharmacology & therapeutics.

Four-food group elimination diet for adult eosinophilic esophagitis: A prospective multicenter study.

A. Lucendo, Á. Arias, J. Barrio, 2014, The Journal of allergy and clinical immunology.

EFFICACY OF THERAPY FOR EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE.

E. Savarino, E. Laserna-Mendieta, A. Lucendo, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Even non-experts identify non-dysplastic lesions in inflammatory bowel disease via chromoendoscopy: results of a screening program in real-life

J. Barrio, L. Fernández-Salazar, M. García-Alvarado, 2019, Endoscopy International Open.

Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow‐up multicenter study

J. Gisbert, C. González, E. Rey, 2016, Journal of gastroenterology and hepatology.

Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry.

E. Savarino, S. Carrión, S. Fernández-Fernández, 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry

E. Savarino, S. Carrión, S. Fernández-Fernández, 2022, United European gastroenterology journal.

[Cholestatic acute hepatitis induced by amoxycillin-clavulanic acid combination. Role of ursodeoxycholic acid in drug-induced cholestasis].

A. Castiella, M. García-Bengoechea, J. Barrio, 1998, Revista Espanola de Enfermedades Digestivas.

Intestinal and biliary infection with Ascaris lumbricoides in gastrointestinal endoscopy.

M. Pérez-Miranda, P. Gil-Simón, A. Caro-Patón, 2009, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Molecular diagnosis of allergy to Anisakis simplex and Gymnorhynchus gigas fish parasites.

S. Martín, J. Barrio, M. González-Sagrado, 2017, Allergologia et immunopathologia.

Pyogenic liver abscesses of bacterial origin. A study of 45 cases.

L. Bujanda, A. Castiella, J. Barrio, 2000, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Temporary Access Fistulas (TAFs) Using Covered Self-Expandable Metal Stents (cSEMS): A Feasible Tool for Interventional Pancreaticobiliary Endoscopy

M. Pérez-Miranda, A. Caro-Patón, J. Barrio, 2007 .

Late disappearance of hepatitis C virus RNA from peripheral blood mononuclear cells in patients with chronic hepatitis C in sustained response after α-interferon therapy

M. García-Bengoechea, J. Barrio, J. Arenas, 1999, American Journal of Gastroenterology.

Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU Study.

M. Sans, X. Calvet, L. Bujanda, 2010, Journal of Crohn's & colitis.

Intestinal and peritoneal tuberculosis in a non-immunocompromised patient ☆

M. Pérez-Miranda, J. Barrio, Félix García, 2016 .

Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry.

J. Gisbert, A. Montserrat, E. Cabré, 2019, Inflammatory bowel diseases.

Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn’s Disease Recurrence. A GETECCU Randomised Trial

J. Gisbert, X. Calvet, J. Barrio, 2017, Journal of Crohn's & colitis.

Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry

X. Calvet, L. Bujanda, J. Barrio, 2019, Surgical Endoscopy.

Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis

L. Bujanda, J. Barrio, A. Gutiérrez, 2020, Clinical and translational gastroenterology.

[Esophageal Crohn's disease].

L. Julian, M. Pérez-Miranda, P. Gil-Simón, 2008, Gastroenterology & hepatology.

Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

J. Gisbert, M. Piqueras, A. Lucendo, 2022, Journal of clinical medicine.

Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)

M. Piqueras, L. Bujanda, D. Busquets, 2022, Journal of clinical medicine.

Su1171 Second-Line Rescue Triple Therapy With Levofloxacin After Failure of Non-Bismuth Quadruple “Sequential” or “Concomitant” Treatment to Eradicate H. pylori Infection

J. Gisbert, J. Barrio, J. Molina-Infante, 2014 .

Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple “sequential” or “concomitant” treatment to eradicate H. pylori infection

J. Gisbert, J. Barrio, J. Molina-Infante, 2013, Scandinavian journal of gastroenterology.

Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice

J. Gisbert, X. Calvet, J. Barrio, 2013, Gut.

Sa1882 Phase IV, Prospective, Randomized and Comparative Study Between Sequential and Concomitant Therapy for Helicobacter pylori Eradication in Routine Clinical Practice

J. Gisbert, X. Calvet, Blanca Belloc, 2013 .

Sa1917 Third-Line Rescue Therapy With Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (With Clarithromycin and Levofloxacin) to Eradicate Helicobacter pylori Infection

J. Gisbert, L. Rodrigo, J. Barrio, 2013 .

[Intestinal and peritoneal tuberculosis in a non-immunocompromised patient].

M. Pérez-Miranda, J. Barrio, Félix García, 2016, Gastroenterologia y hepatologia.

[Diagnostic utility of hepatic hemodynamics study in hepatoportal sclerosis].

J. Barrio, J. Vaquero, R. Bañares, 2001, Gastroenterologia y hepatologia.

Influence of HLADQA1*05 Genotype in Adults With Inflammatory Bowel Disease and Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring: A Retrospective Cohort Study.

F. García-Alonso, J. Barrio, J. A. Garrote, 2023, Inflammatory bowel diseases.

Frequency, predictors, and consequences of maintenance infliximab therapy intensification in ulcerative colitis.

R. Sanchez-Ocana, J. Barrio, L. Fernández-Salazar, 2015, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

Blanca Belloc, D. Hervás, L. Bujanda, 2016, Journal of Gastroenterology.

Follow-Up Study Confirms the Presence of Gastric Cancer DNA Methylation Hallmarks in High-Risk Precursor Lesions

J. Gisbert, M. Esteller, C. González, 2021, Cancers.

Diagnostic and therapeutic management of eosinophilic oesophagitis in children and adults: results from a Spanish registry of clinical practice.

A. Lucendo, L. Rodrigo, Á. Arias, 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[Acute esophageal necrosis. An underdiagnosed disease].

P. Gil-Simón, J. Barrio, R. Atienza, 2008, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Spontaneous bacterial peritonitis by Campylobacter fetus in Budd-Chiari syndrome without liver cirrhosis.

A. Castiella, M. García-Bengoechea, J. Barrio, 1999, Liver.

Acute cholestasis by fluoxetine.

A. Castiella, J. Barrio, J. Arenas, 1996, The American journal of gastroenterology.

Incidence and natural history of inflammatory bowel disease in Castile and León: A prospective, multicentre study

J. Barrio, B. Sicilia, L. Hernández, 2023, Gastroenterología y Hepatología (English Edition).

Severe Sarcoidosis-like reaction in a patient with Crohn's Disease treated with Infliximab. Any relationship?

J. Barrio, E. Fuentes-Valenzuela, C. Navarro Cañadas, 2021, Clinics and research in hepatology and gastroenterology.

Transcultural adaptation and validation of the "Adult Eosinophilic Esophagitis Quality of Life Questionnaire" into Spanish.

A. Lucendo, Á. Arias, J. M. Tenías, 2014, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry.

J. Gisbert, E. Cabré, J. Barrio, 2015, Journal of Crohn's & colitis.

Empirical second-line therapy in 5,000 patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)

F. Mégraud, J. Gisbert, A. Gasbarrini, 2021, Clinical Gastroenterology and Hepatology.

Helicobacter pylori first‐line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp‐EuReg)

F. Mégraud, C. O'Morain, J. Gisbert, 2020, Helicobacter.

Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients.

F. Mégraud, C. O'Morain, J. Gisbert, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection: Time Trends in a Spanish Multicenter Study of 1000 Patients

J. Gisbert, X. Calvet, L. Rodrigo, 2013, Journal of clinical gastroenterology.

European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain

F. Mégraud, C. O'Morain, J. Gisbert, 2020, Antibiotics.

Empirical rescue treatment of Helicobacter pylori infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on H. pylori management (Hp-EuReg)

F. Mégraud, C. O'Morain, J. Gisbert, 2022, Gut.

The Role of Statins on Helicobacter pylori Eradication: Results from the European Registry on the Management of H. pylori (Hp-EuReg)

F. Mégraud, C. O'Morain, J. Gisbert, 2021, Antibiotics.

Room for Improvement in the Treatment of Helicobacter pylori Infection

F. Mégraud, C. O'Morain, J. Gisbert, 2021, Journal of clinical gastroenterology.

Accuracy of the Ultra-Rapid Urease Test for diagnosis of Helicobacter pylori infection.

J. Gisbert, L. Bujanda, J. Barrio, 2017, Gastroenterologia y hepatologia.

Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg)

F. Mégraud, C. O'Morain, J. Gisbert, 2021, The American journal of gastroenterology.

Accuracy of GastroPanel for the diagnosis of atrophic gastritis

J. Gisbert, B. Madrigal, J. Barrio, 2014, European journal of gastroenterology & hepatology.

Accuracy of gastropanel for the diagnosis of atrophic gastritis: Erratum

J. Gisbert, B. Madrigal, J. Barrio, 2014, European Journal of Gastroenterology & Hepatology.

Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU

J. Gisbert, X. Calvet, M. Piqueras, 2021, American Journal of Gastroenterology.

[Macromolecular creatinine kinase in patients diagnosed with ulcerative colitis].

J. Barrio, J. L. Pérez Calle, V. González Lara, 2001, Gastroenterologia y hepatologia.

A retrospective study of pediatric endoscopy as performed in an adult endoscopy unit.

M. Pérez-Miranda, P. Gil-Simón, A. Caro-Patón, 2010, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

P397 Effectiveness of vedolizumab (VDZ) for the induction of remission in inflammatory bowel disease (IBD): Results from the Spanish Eneida Registry

J. Gisbert, X. Calvet, M. Piqueras, 2018 .

Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

J. Gisbert, Blanca Belloc, D. Hervás, 2017, Journal of Gastroenterology.

Genetic variation analysis in a follow‐up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14

J. Gisbert, C. González, J. Sanz-Anquela, 2018, International journal of cancer.

[Recurrent benign intrahepatic cholestasis].

A. Castiella, M. García-Bengoechea, J. Barrio, 2001, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg)

F. Mégraud, C. O'Morain, J. Gisbert, 2023, Gut.

W1193 Safety of Thiopurine Therapy in Inflammatory Bowel Disease (IBD): Long-Term Follow-up Study of 3,900 Patients

J. Gisbert, I. Ordás, E. Cabré, 2010 .

Value of microarray allergen assay in the management of eosinophilic oesophagitis.

S. Martín, J. Barrio, J. Vega, 2015, Allergologia et immunopathologia.

Su1172 Non-Bismuth Quadruple (Concomitant) Therapy for Eradication of H. pylori: Standard vs. Optimized (14-Day, High-Dose PPI) Regimen

J. Gisbert, L. Rodrigo, J. Barrio, 2014 .

Ovesco system for treatment of postpolypectomy bleeding after failure of conventional treatment.

M. Pérez-Miranda, J. Barrio, R. Ruiz-Zorrilla, 2014, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[Spontaneous bacterial peritonitis caused by Streptococcus milleri in a cirrhotic patient with selective intestinal decontamination].

A. Castiella, J. Barrio, J. Arenas, 1998, Gastroenterologia y hepatologia.